KMS Medisurgi financials and balance sheet

BSE: 540468Healthcare Equipment & Supplies

Last traded ₹132.80 on 13 May 2026

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.KMS Medisurgi annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹14 Cr, year to Mar 2025

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue12
  2. Materials and goods−8.8
  3. Employee costs−1.3
  4. Other expenses−1.2
  5. Operating profit0.9
  6. Depreciation−0.5
  7. Other income0.0
  8. Finance costs−0.1
  9. Profit before tax0.3
  10. Tax−0.1
  11. Net profit0.2

What the company owns

  • Plant, investments and other assets₹4 Cr
  • Receivables₹3 Cr
  • Inventory₹3 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹8 Cr
  • Owed to suppliers₹1 Cr
  • Borrowings₹1 Cr
  • Other liabilities₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March.KMS Medisurgi half-yearly results

₹ croreMar 2017Mar 2018Mar 2019Filed 12 JunMar 2020Filed 7 AugMar 2021Filed 6 JulMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 4 JulMar 2025Filed 1 JunMar 2026Filed 1 Jun
Revenue from operations7.97.39.910.37.510.311.013.913.912.2
7.06.9–9.7–9.810.113.113.011.3
Materials and goods bought5.85.68.07.95.87.87.910.710.58.8
Employee costs0.40.5–0.8–0.91.11.21.21.3
Other expenses0.70.8–1.0–1.11.11.11.31.2
Operating profit before depreciation0.90.5–0.7–0.61.00.80.90.9
Operating margin11.9%6.4%–6.4%–5.5%8.7%5.6%6.7%7.4%
Materials, % of revenue74.0%75.9%–76.6%–75.5%71.8%77.4%75.7%72.3%
Employee costs, % of revenue5.6%7.2%–7.3%–8.6%9.6%8.9%8.6%10.7%
Other expenses, % of revenue8.5%10.5%–9.6%–10.4%9.9%8.1%9.1%9.7%
Depreciation and amortisation0.50.5–0.4–0.30.30.30.30.5
Operating profit after depreciation0.50.0–0.3–0.30.60.50.70.4
Other income0.20.40.40.00.10.10.00.10.00.0
Finance costs0.30.20.10.10.00.00.00.00.10.1
One-off items–––0.0––––––
Profit before tax0.40.20.20.20.20.30.70.60.60.3
0.10.10.10.10.10.10.10.20.20.1
Net profit0.20.10.10.10.20.20.60.50.40.2
Net margin2.7%1.3%1.3%1.1%2.1%2.1%5.2%3.3%3.2%2.0%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2019 and Mar 2021: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 12 JunMar 2020Filed 7 AugMar 2021Filed 6 JulMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 4 JulMar 2025Filed 1 JunMar 2026Filed 1 Jun
6.36.36.56.77.27.78.18.3
Share capital3.33.33.33.33.33.33.33.3
Reserves3.03.03.23.43.94.44.85.0
Borrowings1.11.11.01.01.00.50.90.8
3.21.71.92.01.52.61.31.5
Liabilities due after a year1.11.11.01.01.00.50.90.8
Total assets10.59.19.39.79.710.910.310.5
2.27.31.71.52.01.93.03.2
8.31.87.78.27.78.97.37.3
Net debt0.00.80.40.60.80.10.4−0.3
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 6 JulMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 4 JulMar 2025Filed 1 JunMar 2026Filed 1 Jun
0.53−0.060.461.210.741.51
0.620.150.571.480.921.49
0.11−0.35−0.400.56−0.040.69
Receivables−0.78−0.240.010.751.541.02
Inventories0.68−0.300.05−1.17−0.43−0.02
Payables0.230.18−0.871.24−1.140.07
Other working capital−0.020.010.41−0.26−0.01−0.38
Tax paid0.000.00−0.11−0.26−0.17−0.08
Interest paid0.000.000.000.000.000.11
Capital spending0.170.120.660.130.001.72
Free cash flow0.36−0.18−0.201.080.74−0.21
−0.10−0.10−0.66−0.52−0.97−0.61
−0.11−0.040.01−0.460.27−0.26
Dividends paid0.02–0.020.020.020.02
Shares issued0.000.000.000.000.000.00
Net change in cash0.32−0.20−0.200.230.040.64
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020. Dividends paid is left blank for the year to Mar 2022: the cash-flow statement states no dividends paid, while the company's own dividend record shows one paid in the period, so the line is not given. Interest paid is left blank for the year to Mar 2023: the line is filed below nought and is smaller than the rounding of its section's total, so the statement does not show which way it moved cash.

Per share

Standalone, ₹ per share, years to March.KMS Medisurgi dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 12 JunMar 2020Filed 7 AugMar 2021Filed 6 JulMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 4 JulMar 2025Filed 1 JunMar 2026Filed 1 Jun
Earnings per share₹0.89₹0.29–₹0.34₹0.37₹0.65₹1.74₹1.38₹1.33₹0.74
Diluted earnings per share₹0.89₹0.29–₹0.34₹0.37₹0.65₹1.74₹1.38₹1.33₹0.74
Dividend per share₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05
Book value per share––₹18.95₹19.23₹19.56₹20.21₹21.89₹23.22₹24.50₹25.20
Dividend payout–17.2%13.1%14.7%10.4%7.7%2.9%3.6%3.8%6.7%
Shareholder yield––––0.1%––––0.0%
Market cap at the year end (₹ crore)–9.910.010.911.311.4–––41.7
Earnings per share is left blank for the year to Mar 2019: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give. Shareholder yield is left blank for the year to Mar 2022: the cash-flow statement states no dividends paid, while the company's own dividend record shows one paid in the period, so the line is not given.

Ratios

Standalone, years to March.

RatioMar 2017Mar 2018Mar 2019Filed 12 JunMar 2020Filed 7 AugMar 2021Filed 6 JulMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 4 JulMar 2025Filed 1 JunMar 2026Filed 1 Jun
Revenue growth–−7.3%34.6%4.9%−27.4%37.4%6.9%25.9%0.4%−12.4%
Operating profit growth–−49.9%––––70.3%−18.5%18.8%−3.5%
Net profit growth–−55.1%31.6%−11.0%40.8%35.8%166.4%−20.8%−3.1%−44.2%
Earnings per share growth–−67.4%––8.8%75.7%167.7%−20.7%−3.6%−44.4%
––2.0%1.8%2.5%3.3%8.2%6.1%5.6%3.0%
–––−0.2 pts0.7 pts0.8 pts5.0 pts−2.2 pts−0.5 pts−2.6 pts
From the net margin–––−0.3 pts1.7 pts0.0 pts4.9 pts−3.1 pts−0.2 pts−2.0 pts
From asset turnover–––0.2 pts−0.8 pts0.8 pts0.4 pts1.0 pts−0.2 pts−0.4 pts
From borrowing–––−0.1 pts−0.2 pts0.0 pts−0.3 pts−0.1 pts−0.2 pts−0.2 pts
Return on capital employed–––3.4%–3.6%7.8%6.5%7.4%4.7%
Cash conversion––––334.9%−27.3%80.0%266.3%167.8%616.5%
Interest cover1.70.1–3.6–7.03,217.025.58.04.0
Debt to equity––0.180.170.160.150.140.070.110.09
Receivable days––187030523121615211196
Inventory days––82624245427187105
Payable days–––71––––4252
Cash conversion cycle, days–––−8––––156149
Working capital days––148−5253204200154144142
Asset turnover––0.941.050.811.081.141.351.321.17
Assets per rupee of net worth––1.681.561.441.451.401.381.351.27
Sales per rupee of plant––4.47–4.546.976.058.448.304.17
Capital spending to depreciation–––––0.412.080.530.003.65
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
2.4%
Cash from operations against operating profit
168.6%
Measure10 years5 years3 years
Revenue growth, yearly rate–10.2%3.5%
Profit growth, yearly rate–9.2%−24.6%
Return on equity, average–5.2%4.9%
Return on capital employed, average–6.0%6.2%
Operating margin, average–6.8%6.6%
Net margin, average2.4%3.1%2.8%
Asset turnover, average–1.211.28
Cash conversion cycle, days, average––153
Interest cover, average–652.312.5
Debt to equity, average–0.110.09

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations3.863.461.51
Cash from investing−2.87−2.10−0.61
Cash from financing−0.48−0.45−0.26
Capital spending2.631.851.72
Dividends paid–0.050.02
Shares issued for cash0.000.000.00
Borrowings raised–0.370.00
Borrowings repaid0.590.590.14

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Altman Z-scorePublished threshold 1.81–––4.08––––––
Receivables growth less revenue growthOur threshold 0 percentage points–––−104.91–−33.53−6.62−37.46−27.02−11.61
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−24.22−23.429.90−6.3791.4022.5616.98
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−2.861.641.96−2.223.99−4.013.12
Effective tax ratePublished threshold 17.16 per cent39.6146.9639.8438.3633.2524.5513.0024.9127.9125.67
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––24.55−3.26−18.75−0.542.91
A threshold marked as ours has no published figure; it is the line we read the check against.